ZGE-23391-07945
3 vaccinations
9 coded responses
36 check-ins
9 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 433 / OH
- Registered
- 2021-03-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-30
Registered in v-safe
-
2021-03-30
Dose 1 — Moderna
- 2021-03-30
-
2021-03-31
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-01
- 2021-04-02
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-13
- 2021-04-22
-
2021-04-27
Dose 2 — Moderna
- 2021-04-27
-
2021-04-28
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to do your normal daily activitiesFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-29
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-30
Survey response — days 1–6 daily, dose 2MedDRA: Cough — Feeling: Poor · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: CoughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-01
Survey response — days 1–6 daily, dose 2MedDRA: SARS-CoV-2 test positive — Feeling: Poor · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Positive COVID19 test 4/30/21MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-01
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-02
Survey response — days 1–6 daily, dose 2MedDRA: COVID-19 — Feeling: Poor · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: I have COVIDMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-03
Survey response — days 1–6 daily, dose 2MedDRA: COVID-19, Palpitations — Feeling: Poor · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesFree text: Racing heart, I have COVID19MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-04
Survey response — day 7, dose 2MedDRA: COVID-19 — Feeling: Poor · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: COVID +MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-11
- 2021-05-18
- 2021-05-25
- 2021-06-01
- 2021-06-08
-
2021-07-27
Survey response — 3 months, dose 2MedDRA: Vertigo — Feeling: GoodFree text: VertigoMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-10-31
Survey response — 6 months, dose 2MedDRA: Unevaluable event — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Possible post-COVID inflammatory issuesMedDRA releases: 2024-11 · check-in free text available
-
2021-10-31
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-11-03
-
2021-11-04
Dose 3 — Moderna
-
2021-11-05
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, Muscle or body aches, NauseaAdult check-in
-
2021-11-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness, NauseaAdult check-in
- 2021-11-07
- 2021-11-08
-
2021-11-11
Health check-in — day 7, dose 3Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-11-18
-
2021-11-25
Survey response — day 21, dose 3MedDRA: Inflammation — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Post-Covid inflammatory syndromeMedDRA releases: 2024-11 · check-in free text available
-
2021-11-25
Report sent to call center — day 21, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-12-02
- 2021-12-09
- 2021-12-16
- 2022-01-13
- 2022-02-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-30 | Moderna | |
| 2 | 2021-04-27 | Moderna | |
| 3 | 2021-11-04 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-05-01 | Unsuccessful | |
| 2021-10-31 | Unsuccessful | |
| 2021-11-25 | Unsuccessful |
Free text
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Dizziness
Systemic reaction (other): Cough
Systemic reaction (other): Positive COVID19 test 4/30/21
Systemic reaction (other): I have COVID
Systemic reaction (other): Racing heart, I have COVID19
Release 8 — day 7, dose 2
Systemic reaction (other): COVID +
Release 9 — 3 months, dose 2
Symptoms: Vertigo
Release 10 — 6 months, dose 2
Symptoms: Possible post-COVID inflammatory issues
Release 10 — day 21, dose 3
Symptoms: Post-Covid inflammatory syndrome
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Inflammation | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SD | Vertigo | ✓ | · | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
| SRO | COVID-19 | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Palpitations | ✓ | ✓ | ✓ |
| SRO | SARS-CoV-2 test positive | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release